[
    {
        "title": "Oncolyticvirusesfor cancer immunotherapy.",
        "link": "https://pubmed.ncbi.nlm.nih.gov/32600470/"
    },
    {
        "title": "Oncolyticvirusesin melanoma.",
        "link": "https://pubmed.ncbi.nlm.nih.gov/35227006/"
    },
    {
        "title": "Oncolyticvirusesand cancer treatment.",
        "link": "https://pubmed.ncbi.nlm.nih.gov/36868829/"
    },
    {
        "title": "Recent Developments in Glioblastoma Therapy:OncolyticVirusesand Emerging Future Strategies.",
        "link": "https://pubmed.ncbi.nlm.nih.gov/36851761/"
    },
    {
        "title": "Oncolyticvirusesand pancreatic cancer.",
        "link": "https://pubmed.ncbi.nlm.nih.gov/35460973/"
    },
    {
        "title": "OncolyticVirusesand Cancer Immunotherapy.",
        "link": "https://pubmed.ncbi.nlm.nih.gov/36441447/"
    },
    {
        "title": "Tumor Tropism of DNAVirusesforOncolyticVirotherapy.",
        "link": "https://pubmed.ncbi.nlm.nih.gov/38005938/"
    },
    {
        "title": "Engineering strategies to enhanceoncolyticvirusesin cancer immunotherapy.",
        "link": "https://pubmed.ncbi.nlm.nih.gov/35387984/"
    },
    {
        "title": "Recent advances ofoncolyticvirus in cancer therapy.",
        "link": "https://pubmed.ncbi.nlm.nih.gov/32078405/"
    },
    {
        "title": "The emerging field ofoncolyticvirus-based cancer immunotherapy.",
        "link": "https://pubmed.ncbi.nlm.nih.gov/36402738/"
    },
    {
        "title": "Therapy withoncolytic viruses: progress and challenges",
        "link": "https://www.nature.com/articles/s41571-022-00719-w"
    },
    {
        "title": "[HTML][HTML]Oncolytic virusesfor cancer immunotherapy",
        "link": "https://link.springer.com/article/10.1186/s13045-020-00922-1"
    },
    {
        "title": "[HTML][HTML]Clinical landscape ofoncolytic virusresearch in 2020",
        "link": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552841/"
    },
    {
        "title": "[HTML][HTML]Clinical application ofoncolytic viruses: a systematic review",
        "link": "https://www.mdpi.com/1422-0067/21/20/7505"
    },
    {
        "title": "Integratingoncolytic virusesin combination cancer immunotherapy",
        "link": "https://www.nature.com/articles/s41577-018-0014-6"
    },
    {
        "title": "[HTML][HTML]Oncolytic virusesfor cancer therapy: barriers and recent advances",
        "link": "https://www.cell.com/molecular-therapy-family/oncology/fulltext/S2372-7705(19)30097-X"
    },
    {
        "title": "[HTML][HTML]Oncolytic virusimmunotherapy: future prospects for oncology",
        "link": "https://link.springer.com/article/10.1186/s40425-018-0458-z"
    },
    {
        "title": "[HTML][HTML]Oncolytic virusesand the immune system: the dynamic duo",
        "link": "https://www.cell.com/molecular-therapy-family/methods/fulltext/S2329-0501(20)30011-5"
    },
    {
        "title": "Oncolytic virusesas engineering platforms for combination immunotherapy",
        "link": "https://www.nature.com/articles/s41568-018-0009-4"
    },
    {
        "title": "[HTML][HTML]Design and application ofoncolytic virusesfor cancer immunotherapy",
        "link": "https://www.sciencedirect.com/science/article/pii/S0958166919301326"
    }
]